Latest News
Tilray Brands is now ranked among the top 10 undervalued stocks in the Healthcare sector on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company Valuation methodology provided...
Tilray Brands is now ranked among the top 25 undervalued stocks listed on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company Valuation methodology provided by Stockcalc (see...
Inside the Market’s roundup of some of today’s key analyst actions
A survey of North American equities heading in both directions
The company says the loss amounted to four cents US per diluted share for the quarter ended Aug. 31 compared with a loss of 10 cents US per diluted share a year earlier
LEAMINGTON, Ont. — Cannabis company Tilray Brands Inc. reported a loss of US$34.7 million in its first quarter, compared with a loss of US$55.9 million in the same quarter last year, as its net revenue rose 13 per cent.
Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2025 Financial Results on October 10, 2024
Jobs Figures Due Next Week South of the Border
Monday U.S. Economic Lookahead Chicago Business Barometer (Sept.) Featured EarningsCarnival ...
Top Analyst Ratings Apple (AAPL) – Evercore: Buy, Target Price USD 250 (09/26/2024) Evercore has reaffirmed its “Buy” rating on Apple, setting a target price of $250. The firm remains confident in Apple’s strong product pipeline and robust ecosystem, particularly with anticipated innovations in its hardware and software offerings. Analysts...